Company Overview of Therapix Biosciences Ltd.
Therapix Biosciences Ltd., a biopharmaceutical company, identifies and develops immunotherapy products. It offers oral antibody Anti-CD3 to treat inflammatory and autoimmune illnesses, as well as other diseases related to autoimmune disorders. The company is also involved in developing antibodies to treat Alzheimer's disease. In addition, it provides LP-306, a novel pharmaceutical product based on cannabinoids for pain management; and TRX-318, an oral monoclonal antibody for auto-immune and inflammatory diseases. The company sells its products to pharmaceutical and biotechnology companies that treat metabolic disorders and liver diseases in Israel, the United States, Europe, and Australia. I...
18 Einstein Street
Founded in 2004
Key Executives for Therapix Biosciences Ltd.
Therapix Biosciences Ltd. does not have any Key Executives recorded.
Therapix Biosciences Ltd. Key Developments
Therapix Biosciences Ltd. Presents at 7th annual Biotech Showcase Conference 2015, Jan-14-2015 11:30 AM
Dec 18 14
Therapix Biosciences Ltd. Presents at 7th annual Biotech Showcase Conference 2015, Jan-14-2015 11:30 AM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
Therapix Bio Names Jan Turek as Chief Executive Officer
Oct 20 14
Therapix Bio announced that Jan Turek has been named Chief Executive Officer, effective as of September 22, 2014. As CEO, he will lead the company's strategic growth initiatives, including the acquisition of and investment in cannabinoid-focused companies and technologies, and the development of these assets. Turek joins Therapix with over 30 years' experience in biotech and pharmaceutical executive leadership, product development, marketing and business development. As a Partner at TCG, LLC, he has been a senior strategy and transaction advisor to a number of large and small biopharmaceutical companies.
Therapix Biosciences Ltd., Special/Extraordinary Shareholders Meeting, Aug 21, 2014
Jul 17 14
Therapix Biosciences Ltd., Special/Extraordinary Shareholders Meeting, Aug 21, 2014., at 10:00 Israel Standard Time.
Similar Private Companies By Industry
Recent Private Companies Transactions